Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;9(2):108-12.
doi: 10.4088/pcc.v09n0204.

Safety and efficacy of bupropion extended release in treating a community sample of Hispanic and african american adults with major depressive disorder: an open-label study

Paul K Gross  1 , Rosemary Nourse, Thomas E Wasser, Deo Bukenya
Affiliations

Safety and efficacy of bupropion extended release in treating a community sample of Hispanic and african american adults with major depressive disorder: an open-label study

Paul K Gross et al. Prim Care Companion J Clin Psychiatry. 2007.

Abstract

Objectives: Many publications and federal agencies call for more trials and research on the effectiveness of medications and treatment needs in diverse patient populations with psychiatric disorders. This study investigates the effectiveness of bupropion extended release (XL) on a community sample of men and women of either Hispanic or African American heritage with major depressive disorder (MDD).

Method: Twenty-six patients of Hispanic or African American descent with MDD as diagnosed by means of the Structured Clinical Interview for DSM-IV Axis I Disorders were required to have a score of 20 or greater on the Hamilton Rating Scale for Depression (17-item) (HAM-D-17) at baseline and prior to randomization. Patients were also required to have a score of 4 or greater on the Clinical Global Impressions-Severity of Illness scale (CGI-S) at baseline and prior to initiation of treatment. Patients were treated openly for an optimum of 9 weeks. Bupropion XL was initiated at 150 mg daily and then increased to 300 mg daily after 1 week and 450 mg daily 4 weeks later if judged clinically necessary by the investigator. Tools utilized for repeated-measures methodology indicating efficacy were the HAM-D-17, CGI-S, Clinical Global Impressions-Improvement scale (CGI-I), Change in Sexual Functioning Questionnaire (CSFQ), and the 18-item Motivation and Energy Inventory. The study was conducted from February 9, 2005, to March 23, 2006.

Results: Efficacy was demonstrated on the HAM-D-17, CGI-S, CGI-I, and CSFQ (p < .05). Mean times ranged from 50% symptom reduction in about 2 weeks to 90% symptom reduction in less than 2 months. Dry mouth, transient stomach discomfort, and headache were the most commonly reported side effects.

Conclusions: Data from this 10-week open-label study suggest bupropion XL is an effective and well tolerated treatment for depressive symptoms in the moderately to markedly ill Hispanic and African American community.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Oquendo MA, Ellis SP, and Greenwald S. et al. Ethnic and sex differences in suicide rates relative to major depression in the United States. Am J Psychiatry. 2001 158:1652–1658. - PubMed
    1. US Department of Health and Human Services, Office of Minority Health. Hispanic/Latino Profile. Available at: http://www.omhrc.gov/templates/browse.aspx?lvl=2&lvlID=54. Accessed May 10, 2006.
    1. National Mental Health Association. African American Outreach. Available at: http://www.mhanj.org/Fact_sheets/African%20American%20Outreach%20Factshe... Accessed May 10, 2006.
    1. Plant E, Sachs-Ericsson N.. Racial and ethnic differences in depression: the roles of social support and meeting basic needs. J Consult Clin Psychol. 2004;72:41–52. - PubMed
    1. Hernandez A, Plant EA, and Sach-Ericsoon N. et al. Mental health among Hispanics and Caucasians: risk and protective factors contributing to prevalence rates of psychiatric disorders. J Anxiety Disord. 2005 19:844–860. - PubMed